Intervention

Glatiramer Acetate, IFN-beta 1a (IM), IFN-beta 1a (Subcutaneous), and IFN-beta 1b

ClinicalTrials.gov intervention label

Clinical trials1

Recruiting0

Common conditions1

Lead sponsors shown1

Clinical trials

1 shown

Therapy Optimization in Multiple Sclerosis (MS)NCT00819000 · 2008-12-01

COMPLETED

Common conditions

Multiple Sclerosis1

Leading sponsors

Teva Neuroscience, Inc.1

Trial status mix

COMPLETED1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.